Biomarkers for Alzheimer’s Disease Drug Development

Häftad, Engelska, 2025

1 889 kr

Beställningsvara. Skickas inom 10-15 vardagar

Fri frakt för medlemmar vid köp för minst 249 kr.

This fully updated volume provides an up-to-date and comprehensive overview of the current state of technologies helping to accelerate Alzheimer’s disease drug development.

Produktinformation

Utgivningsdatum2025-05-22
Mått178 x 254 x 20 mm
Vikt684 g
FormatHäftad
SpråkEngelska
SerieMethods in Molecular Biology
Antal sidor347
Upplaga2
FörlagSpringer-Verlag New York Inc.
ISBN9781071637760

Tillhör följande kategorier

Medicinsk utrustning och medicinska tekniker inom Medicin
Alzheimer, demens inom Medicin
Biovetenskap inom Naturvetenskap och teknik

Blood-Based Biomarkers for Early Alzheimer’s Disease Diagnosis in Real-World Settings.- Alzheimer’s Disease Prevention and Treatment Based on Population-Based Approaches.- CSF N-Glycomics Using High Throughput UPLC-ESI Techniques in Alzheimer’s Disease.- CSF N-Glycomics Using MALDI MS Techniques.- Optimized Pre-Analytical Handling Protocol for Blood-Based Biomarkers of Alzheimer’s Disease.- Mass Spectrometry-Based Metabolomics Multi-Platform for Alzheimer’s Disease Research.- Analysis of Resting-State Functional Magnetic Resonance Imaging in Alzheimer's Disease.- Diffusion Tensor Imaging in Alzheimer’s Studies.- Magnetic Resonance Spectroscopy (MRS) in Alzheimer’s Disease.- Neuroimaging Methods for MRI Analysis in CSF Biomarkers Studies.- Amyloid PET Imaging: Standard Procedures and Semiquantification.- PET Imaging to Measure Neuroinflammation In Vivo.- Imaging Neuroinflammation: Quantification of Astrocytosis in a Multitracer PET Approach.- High-Throughput Lipidomics and Metabolomics Profiling for Brain Tissue and Biofluid Samples in Neurodegenerative Disorders.- Neuropathological Assessment as an Endpoint in Clinical Trial Design.- Non-Invasive Visualization of Amyloid-Beta Deposits in Alzheimer’s Amyloidosis Mice via Fluorescence Molecular Tomography Using Contrast Agent.- Brain Banking in Dementia Studies.- Speech-Based Digital Biomarkers for Alzheimer’s Research.- cCOG Web-Based Cognitive Assessment Tool.- In Silico Models to Validate Novel Blood-Based Biomarkers.